Abbott Laboratories
ABT
You’ve read what changed. Here’s whether the market is confirming it.
Jodie situation report
Abbott Laboratories's move is being confirmed by its market group.
ABT accounts for 0.3% of the group's measured movement across 6.7 effective names. raw member direction is mixed; 6 of 12 SPY-adjusted paths align to the upside. Capital-flow agreement is 21%, so confirmation is not yet clean. No verified headline preceded the measured group move.
MOVE ANATOMY
SPY-adjusted 5m pathsIs this move genuinely shared?
Role in the moveFlat / inactive path#12 of 12 by movement share
Group movement share0.3%Absolute path energy—not portfolio weight
Relative path+0.03%flat
Effective breadth6.7 / 12broad
Relative alignment6/12upside path · 4 counter-moving
Capital-flow agreement21%not yet clean
SEQUENCE READ
MDT, GMED, EW moved materially before ABT. ABT crossed its material path threshold at 10:10 ET. LFST followed.
EVIDENCE COVERAGE
15 of 18 members in Medical Devices & Supplies are active. 0 of 8 disclosed connections are confirming.
What would change this read
Watch this read- At least 12 of 18 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as UFPT begins moving with the group.
Invalidation: The live read weakens if participation falls to 6 of 18 members or fewer.